{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:05:01Z","timestamp":1785542701903,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005196","name":"Bureau of Justice Assistance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.drugalcdep.2019.107693","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T12:28:47Z","timestamp":1572265727000},"page":"107693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Overlapping prescriptions of opioids, benzodiazepines, and carisoprodol: \u201cHoly Trinity\u201d prescribing in the state of Florida"],"prefix":"10.1016","volume":"205","author":[{"given":"Yanning","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Delcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Goldberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Reisfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.107693_bib0005","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/clpt.2011.250","article-title":"Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential","volume":"91","author":"Bramness","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0010","series-title":"2017 National Survey on Drug Use and Health: Detailed Tables","author":"Center for Behavioral Health Statistics and Quality","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain--United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0020","series-title":"2016\u20132017 Prescription Drug Monitoring Program Annual Report (E-FORCSE)","author":"Florida Department of Health","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0025","series-title":"2015\u20132016 Prescription Drug Monitoring Program Annual Report (E-FORCSE)","author":"Florida Department of Health","year":"2016"},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/10550887.2011.554778","article-title":"Ingestions of hydrocodone, carisoprodol, and alprazolam in combination reported to Texas poison centers","volume":"30","author":"Forrester","year":"2011","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0035","series-title":"Kentucky House Bill 1 Impact Evaluation (Evaluation)","author":"Freeman","year":"2015"},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/j.pain.0000000000001078","article-title":"High-risk prescribing and opioid overdose: prospects for prescription drug monitoring program\u2013based proactive alerts","volume":"159","author":"Geissert","year":"2018","journal-title":"PAIN"},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0045","first-page":"180","article-title":"Abuse potential of soma: the GABA(A) receptor as a target","volume":"1","author":"Gonzalez","year":"2009","journal-title":"Mol. Cell. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0050","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.109.151142","article-title":"Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies","volume":"329","author":"Gonzalez","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0055","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.amepre.2018.06.008","article-title":"Opioid prescribing by specialty and volume in the U.S","volume":"55","author":"Guy","year":"2018","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0060","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1370\/afm.2285","article-title":"Opioid-prescribing continuity and risky opioid prescriptions","volume":"16","author":"Hallvik","year":"2018","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0065","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0919","article-title":"Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in medicare part d beneficiaries","volume":"1","author":"Hernandez","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0070","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.drugalcdep.2016.11.020","article-title":"Validation of prescriber risk indicators obtained from prescription drug monitoring program data","volume":"173","author":"Kreiner","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0075","series-title":"Personal Communication","author":"Lawrence Scholl (Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC)","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0080","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1177\/0960327116672912","article-title":"Pharmacokinetic modeling of carisoprodol and meprobamate disposition in adults","volume":"36","author":"Lewandowski","year":"2017","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2019.05.025","article-title":"Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis","volume":"202","author":"Li","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0090","doi-asserted-by":"crossref","DOI":"10.1111\/jep.12756","article-title":"Safer and more appropriate opioid prescribing: a large healthcare system\u2019s comprehensive approach","author":"Losby","year":"2017","journal-title":"J. Eval. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7812\/TPP\/16-169","article-title":"Physician guide to appropriate opioid prescribing for noncancer pain","volume":"21","author":"Munzing","year":"2017","journal-title":"Perm. J."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0100","series-title":"CDC Compilation of Benzodiazepines, Muscle Relaxants, Stimulants, Zolpidem, and Opioid Analgesics with Oral Morphine Milligram Equivalent Conversion Factors, 2017 Version","author":"National Center for Injury Prevention and Control","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jsr.2012.08.009","article-title":"Prescription drug overdoses: a review","volume":"43","author":"Paulozzi","year":"2012","journal-title":"J. Safety Res."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6409a1","article-title":"Controlled substance prescribing patterns \u2014 prescription behavior surveillance system, eight states, 2013","volume":"64","author":"Paulozzi","year":"2015","journal-title":"Surveill. Summ."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0115","first-page":"365","article-title":"Choosing a skeletal muscle relaxant","volume":"78","author":"See","year":"2008","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0120","article-title":"Screening, Brief Intervention, and Referral to Treatment in a Retail Pharmacy Setting: The Pharmacist\u02bcs Role in Identifying and Addressing Risk of Substance Use Disorder","volume":"1","author":"Shonesy","year":"2019","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2019.107693_bib0125","first-page":"1","article-title":"Drug poisoning deaths in the United States, 1980\u20132008","author":"Warner","year":"2011","journal-title":"NCHS Data Brief"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619304703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619304703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:08:10Z","timestamp":1759828090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619304703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":25,"alternative-id":["S0376871619304703"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107693","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overlapping prescriptions of opioids, benzodiazepines, and carisoprodol: \u201cHoly Trinity\u201d prescribing in the state of Florida","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107693"}}